300+ investors in your industry, stage, and region Get
Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
Platforms
InsurTech
Oil and Gas
Social Impact
Retail
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Fitness
Organic Food
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
Social Network
B2B
Medical Device
Video Games
Big Data
Mobile
Automotive
Sports
Wellness
Legal
eSports
Education
Construction
Hospitality
Biotechnology
Consumer
Software
Renewable Energy
Crowdfunding
Venture Capital
Fashion
Social
Beauty
Infrastructure
Theatre
Cannabis
LGBT
Celebrity
Climate
Mobile Apps
Life Science
Wine and Spirits
Food and Beverage
Publishing
Music
Art
Real Estate
Sporting Goods
Manufacturing
Digital Media
FinTech
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Medical
Non Profit
Internet
Android
Sustainability
Hardware
Biotech
Impact
Proptech
Recruiting
Transportation
Enterprise
Community
Media (Entertainment)
Web3
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Africa
Gibraltar
Oceania
Liberia
Taiwan
Tunisia
Mexico
Sweden
Zimbabwe
Zambia
Norway
Tajikistan
Nigeria
Russian Federation
Togo
Guinea
Nepal
Isle of Man
Iran
Madagascar
Pakistan
Romania
Poland
Oman
Puerto Rico
Cameroon
Guernsey
Andorra
Colombia
Sudan
Armenia
China
Czech Republic
Costa Rica
Kuwait
Kenya
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Morocco
Moldova
Seychelles
Botswana
Paraguay
Ireland
Japan
South Africa
France
Georgia
Denmark
Ghana
Iraq
Mali
Latvia
Malaysia
Portugal
Philippines
Sierra Leone
Rwanda
El Salvador
Senegal
Tanzania
Germany
India
Canada
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Cyprus
Qatar
Argentina
Bangladesh
Belgium
Barbados
Jordan
Austria
Ethiopia
Azerbaijan
Bulgaria
Ecuador
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Bolivia
Algeria
Belize
Finland
Italy
Belarus
Hungary
Grenada
Israel
Iceland
Cambodia
Honduras
Lithuania
Liechtenstein
Lebanon
Mongolia
United Kingdom
Peru
San Marino
Slovenia
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 50 Life Science Startup Investors in France (August 2026)

The most active venture capital funds and angel investors investing in France Life Science startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in France Life Science startup companies. Find investors to raise a Seed, Series A or Series B round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
Bpifrance
VC Fund
23 France, United States, Switzerland Seed, Series A Software, Information Technology, Health Care $757k–$34M
Kurma Partners
VC Fund
8 France, Switzerland, Spain Series A, Seed, Series B Health Care, Biotechnology, Medical $2.7M–$98M
Omnes Capital
VC Fund
6 France, Germany, United States Series A, Series B Software, Biotechnology, Health Care $3.5M–$53M
Seventure Partners
VC Fund
6 France, United States, Germany Series A, Series B Biotechnology, Health Care, Software $3.3M–$63M
Elaia
VC Fund
5 France, United States, Spain Seed, Series A, Series B Software, Artificial Intelligence, Information Technology $1.1M–$50M
Eurazeo
VC Fund
5 France, United States, Germany Series B, Seed Software, Information Technology, Health Care $3.2M–$125M
Sofinnova Partners
VC Fund
5 France, United States, United Kingdom Series A, Series B, Series C Biotechnology, Health Care, Medical $6.6M–$109M
Angels Santé
VC Fund
4 France, India, United States Seed, Angel Health Care, Biotechnology, Medical Device $658k–$4.6M
Paca Investissement
VC Fund
4 France Seed, Series A Software, Internet, Manufacturing $329k–$9.2M
AdBio partners
VC Fund
4 France, Spain, Belgium Seed, Series A, Venture - Series Unknown Biotechnology, Health Care, Pharmaceutical $2.2M–$37M
Idinvest Partners
VC Fund
4 France, United States, Spain Series B, Series A Biotechnology, Health Care, Software $3.3M–$66M
XAnge
VC Fund
3 France, Germany, Belgium Series A, Seed, Series B Software, SaaS, E-Commerce $1.1M–$75M
Boehringer Ingelheim Venture Fund
VC Fund
3 United States, Germany, Switzerland Series A, Series B, Seed Biotechnology, Health Care, Therapeutics $1.8M–$50M
Karista
VC Fund
3 France, United States, Finland Seed, Series A, Series B Software, Biotechnology, Health Care $713k–$33M
Galia Gestion
VC Fund
3 France, United States Series A, Seed Software, Manufacturing, Biotechnology $531k–$6.9M
Blue Horizon Corporation
VC Fund
3 United States, United Kingdom, Germany Seed, Series A, Pre-Seed Food and Beverage, Food Processing, Biotechnology $450k–$40M
Advent Life Sciences
VC Fund
3 United States, United Kingdom, France Series A, Series B Biotechnology, Health Care, Medical $5.5M–$97M
Partech
VC Fund
2 United States, France, Germany Series A, Seed, Series B Software, E-Commerce, SaaS $1.1M–$55M
WiSEED
VC Fund
2 France, Norway Seed, Series A Software, Biotechnology, Manufacturing $384k–$7.8M
Bertrand Jacquelot
Angel
2 France, United States Pre-Seed, Seed, Angel Food and Beverage, E-Commerce, Information Technology $120k–$7.8M
Beyond Impact
VC Fund
2 France, Canada, Singapore Seed, Series A, Pre-Seed Food and Beverage, Food Processing, Alternative Protein $670k–$48M
Social Starts
VC Fund
2 United States, Germany, Canada Seed, Series A Software, Health Care, Artificial Intelligence $100k–$15M
Andrew Nutter
Angel
2 France, United Kingdom, United States Seed, Pre-Seed, Series A Software, SaaS, FinTech $550k–$4.9M
Invus
VC Fund
2 United States, France, China Series B, Series C, Series A Biotechnology, Health Care, Therapeutics $14M–$230M
European Commission
VC Fund
2 France, Spain, Germany Grant, Seed, Pre-Seed Software, Biotechnology, Health Care $55k–$74M
Bernard Majoie
Angel
2 France, Belgium Seed, Pre-Seed, Series A Biotechnology, Medical, Health Care $1.3M–$2.7M
AQUITI Gestion
VC Fund
2 France, United States Series A, Seed Software, Biotechnology, Manufacturing $170k–$18M
Entrepreneurs First
VC Fund
2 United Kingdom, United States, India Pre-Seed, Seed, Series A Artificial Intelligence, Software, Information Technology $55k–$45M
Kinled Holding
VC Fund
2 United Kingdom, United States, Switzerland Seed, Series A Biotechnology, Health Care, Software $594k–$40M
Eutopia VC
VC Fund
2 France, Belgium, Denmark Seed, Series A, Venture - Series Unknown E-Commerce, Retail, Food and Beverage $1.3M–$48M
Sofimac Investment Managers
VC Fund
2 France, Italy, Austria Seed, Series A Biotechnology, Health Care, Manufacturing $274k–$15M
Point Nine
VC Fund
2 Germany, United States, France Seed, Series A, Series B Software, SaaS, Internet $900k–$62M
Lundbeckfonden Ventures
VC Fund
2 United States, Denmark, United Kingdom Series B, Series A, Series C Biotechnology, Health Care, Therapeutics $10M–$95M
IRDI SORIDEC Gestion
VC Fund
2 France, Brazil, Singapore Seed, Series A Software, Biotechnology, Medical $1.6M–$13M
Alexandria Venture Investments
VC Fund
2 United States, Canada, France Series A, Series B, Seed Biotechnology, Health Care, Therapeutics $2M–$150M
JDRF T1D Fund
VC Fund
2 United States, Canada, France Series A, Series B Biotechnology, Health Care, Medical $7M–$130M
Air Street Capital
VC Fund
2 United States, United Kingdom, France Seed, Series A, Series B Artificial Intelligence, Software, Biotechnology $2.6M–$300M
Thia Ventures
VC Fund
2 United States, France, Denmark Series A, Seed, Pre-Seed Biotechnology, Health Care, Manufacturing $3.4M–$48M
Heartcore Capital
VC Fund
2 Denmark, United States, Germany Seed, Series A, Series B Software, Artificial Intelligence, FinTech $1.3M–$58M
Horizons Ventures
VC Fund
2 United States, United Kingdom, Canada Series A, Series B, Seed Biotechnology, Software, Artificial Intelligence $1M–$110M
Siparex Groupe
VC Fund
2 France, United States, Italy Private Equity, Seed Manufacturing, Software, Information Technology $658k–$27M
Wendel Growth
VC Fund
2 France, Luxembourg Series A, Venture - Series Unknown Analytics, Open Source, Biotechnology $16M–$38M
Polytechnique Ventures
VC Fund
2 France, United Kingdom, Germany Seed, Series A, Pre-Seed Biotechnology, Robotics, Information Technology $1.3M–$17M
Sylvain Zimmer
Angel
2 France, United States, United Kingdom Seed, Pre-Seed, Angel Software, SaaS, Food and Beverage $200k–$10M
Roche Venture Fund
VC Fund
1 United States, United Kingdom, Spain Series B, Series A, Series C Biotechnology, Health Care, Therapeutics
Sofipaca
VC Fund
1 France Private Equity, Series A, Series B Food and Beverage, Pharmaceutical, Manufacturing
Afone Participations
VC Fund
1 France Series A Software, Compliance, Life Science
Calao Finance
VC Fund
1 France, United States Series A, Series B Information Technology, Software, Big Data
Capitole Angels
VC Fund
1 France Seed, Angel Information Technology, Software, 3D Technology
Societe Generale Asset Management
VC Fund
1 France, United States, Germany Series B, Series A Biotechnology, Software, Health Care
Access all 309 investors in France Life Science startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

Bpifrance
VC Fund · Maisons-alfort, Ile-de-France, France · 23 investments in France Life Science startups

Bpifrance provides financial solutions for companies that are booting up the listing on the stock exchange and credit equity. It includes OSEO, CDC Entreprises, FSI, and FSI Regions to offer in your area of financial solutions at every stage of the life of your business.

Show more...

Investment focus

  • Industry: Software, Information Technology, Health Care
  • Stage:Seed, Series A
  • Geography: France, United States, Switzerland

Investor stats

  • Total investments: 1458
  • Round size: Seed $757k–$6.3M; Series A $3M–$34M
  • Lead/follow: 26% lead, 74% follow
  • Last fund: Likely actively investing — fund raised in 2025

Portfolio highlights

  • FinKey — Finkey : la meilleure solution pour vendre sa PME au juste prix. Un accompagnement sur-mesure des chefs d'entreprise.
  • Proteor — Proteor offers a complete range of high quality products and services to the O&P world, through more than 60 clinics.
  • Nepsis — AI-powered software and debt advisory for renewable energy developers. Modern financing solutions for small & medium renewable projects.
Show all investments...

Kurma Partners
VC Fund · Paris, Ile-de-France, France · 8 investments in France Life Science startups

Kurma Partners is a management company based in Paris, specializing in the financing of innovation in healthcare and biotechnology, from pre-creation to development capital. Kurma Partners, which manages the Kurma Biofund I, II funds and the Kurma Diagnostics fund, is one of the main players in the financing of therapeutic and medical innovationsin Europe, particularly through links with many institutes. research and prestigious hospitals.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series A, Seed, Series B
  • Geography: France, Switzerland, Spain

Investor stats

  • Total investments: 142
  • Round size: Seed $2.7M–$14M; Series A $3.8M–$98M; Series B $12M–$72M
  • Lead/follow: 47% lead, 53% follow
  • Last fund: Likely actively investing — fund raised in 2024

Portfolio highlights

  • EvlaBio — EvlaBio is a biotech company focused on the development of drug programs that address significant unmet medical needs. The company's pipeline includes robust scientific antibody programs for the treatment of hepatocellular carcinoma (Phase 1 ready) and chronic kidney disease with left ventricular hypertrophy (pre-clinical).
  • Tacalyx — Tacalyx develops therapeutics targeting cancer-specific carbohydrate antigens on the surface of metastatic malignant tumors where no satisfactory treatments exist.The name Tacalyx is derived from TACA (Tumor Associated Carbohydrate Antigen) and ‘lyx’ from the term Glycocalyx, the glycan-containing layer covering cells. Cancer cells differ fromnormal cells by displaying aberrant carbohydrate structures on their surfaces promoting metastasis, angiogenesis or suppression of the immune system. TACAs result from the aberrant glycosylation that is seen with transformation to a tumor cell and represent attractive targets for cancer treatment since they are displayed with high cancer specificity and enhance tumor virulence via the mentioned diverse mechanisms.
  • AM Pharma — AM-Pharma B.V., a biopharmaceutical company, engages in the development and commercialization of therapeutics for human use in the Netherlands. It focuses in the pre-clinical and clinical development of novel therapeutics to treat inflammatory and infectious diseases. The company develops products based on endogenous proteins and protein derivedpeptides, as well as molecules that naturally occur in the human body. Its products include alkaline phosphatase for treatment of acute kidney injury and ulcerative colitis; and immune response amplifying peptide hLF1-11 for the treatment of drug resistant hospital acquired infections. The company was founded in 2000 and is headquartered in Bunnik, the Netherlands.
Show all investments...

Omnes Capital
VC Fund · Paris, Ile-de-France, France · 6 investments in France Life Science startups

Omnes Capital takes a unique approach to renewable energy, transforming developers into independent power producers to provide green energy to millions.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Health Care
  • Stage:Series A, Series B
  • Geography: France, Germany, United States

Investor stats

  • Total investments: 184
  • Round size: Series A $3.5M–$41M; Series B $4.4M–$53M
  • Lead/follow: 27% lead, 73% follow
  • Last fund: May invest from a new fund soon — raised $403M in 2020

Portfolio highlights

  • VSORA — VSORA provides high performance companion solutions combining AI and signal processing to enable autonomous driving and ADAS
  • SeqOne Genomics — Healthcare is undergoing a revolution, known as genomic medicine, that uses the patient’s genomic information to optimise treatment. This trend is accelerating thanks to the arrival of New Generation Sequencing (NGS) techniques that have reduced the cost of decoding genomic material while increasing the amount useful data obtained. However, NGShas had only limited impact on mainstream healthcare due to the difficulties in analyzing more and richer genomic data. SeqOne’s mission is to provide tools that enable the healthcare industry to analyse NGS genomic data better and more cost-effectively to provide universal access to genomic medicine.
  • Complix — Complix is a biopharmaceutical company focused on the discovery and development of Alphabodiesâ„¢, a novel class of biopharmaceuticals that offer significant advantages over existing protein based therapies. Alphabodiesâ„¢ bind with high affinity to a wide range of disease targets and are particularly suited to address certain targets that aredifficult to reach with antibodies or other types of protein scaffolds. Due to their unique stability and versatility Alphabodiesâ„¢ can be delivered via alternative non-injectable routes of administration, unlike most therapeutic proteins.
Show all investments...

Seventure Partners
VC Fund · Paris, Ile-de-France, France · 6 investments in France Life Science startups

Seventure Partners is a French venture capital firm targeting in Tech/Digital and Life Sciences companies. It funds innovation and participates in the entrepreneurial adventure, alongside entrepreneurs and sharing their passion.Founded in 1997, Seventure Partners is one of the European leaders in venture capital, with € 1 billion undermanagement as of December 31, 2023. It is an active partner of innovative companies that, according to the management team, show strong growth potential and evolving in two fields of activity: Digital Technologies and Life Sciences. With more than 20 employees, including some 15 investors, Seventure Partners has a proven track record and in-depth expertise in technology, entrepreneurship, and various private equity operations.Seventure's goal is to identify and support the development of tomorrow's European leaders in order to accelerate their growth. To do this, the firm provides entrepreneurs with the expertise, networks, and know-how of its internal team of investors.The different funds/verticals on which Seventure Partners are focusing on today: - Life Sciences : Biotech, Healthcare, Nutrition - Tech/Digital : B2B SaaS, Fintech, Retailtech, Cybersecurity - Sports & Wellbeing - Blue Economy

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Series A, Series B
  • Geography: France, United States, Germany

Investor stats

  • Total investments: 247
  • Round size: Series A $3.3M–$28M; Series B $3.4M–$63M
  • Lead/follow: 36% lead, 64% follow
  • Last fund: May invest from a new fund soon — last raise in 2019

Portfolio highlights

  • Ekstere — Ekstere facilitates selling and purchasing verified-quality used bicycles at a reasonable price.
  • Pitchy — Create professional videos without technical expertise. Our online video editor helps you easily make business videos.
  • Presto Engineering — We enable companies imagine and implement microelectronics solutions in high-value markets such as Industrial, Automotive, Communication and Medical.
Show all investments...

Elaia
VC Fund · Paris, Ile-de-France, France · 5 investments in France Life Science startups

Elaia is French venture capital firm focused on European digital and deep tech startups, from early stage to growth developpement. We back tech disruptors.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Information Technology
  • Stage:Seed, Series A, Series B
  • Geography: France, United States, Spain

Investor stats

  • Total investments: 223
  • Round size: Seed $1.1M–$9.9M; Series A $2.2M–$26M; Series B $4.2M–$50M
  • Lead/follow: 46% lead, 54% follow
  • Last fund: Likely still investing — fund raised in 2024

Portfolio highlights

  • Hema.to — Hema.to provides fully automated, AI-powered blood cancer detection suggestions based on flow cytometry data.
  • Ornikar — Ornikar is an online driving school that offers radically cheaper, uncomplicated and faster offer to obtain a driving license.Ornikar relies on a network of state-qualified teachers to offer an apprenticeship in mobile driving at reduced prices. The cmpany is an an online driving school more in tune with the demand of current and futuregenerations.The company's mission is to make the driver's license exam cheaper and its learning more enjoyable.
  • Stanley Robotics — Stanley Robotics is a DeepTech business helping the transportation and logistics industries digitalise and robotise outdoor operations.
Show all investments...

Eurazeo
VC Fund · Paris, Ile-de-France, France · 5 investments in France Life Science startups

Eurazeo is a private equity and venture capital firm that invests in SMEs and manages a diversified portfolio of assets.With its expertise in private equity, real estate, and private debt, the group supports companies of all sizes in their development commitment through the commitment of its 235 professionals. It provides companies with thenecessary investments needed to realize their growth potential.The firm was founded in 1969 and is based in Paris, Ile-de-France, France.

Show more...

Investment focus

  • Industry: Software, Information Technology, Health Care
  • Stage:Series B, Seed
  • Geography: France, United States, Germany

Investor stats

  • Total investments: 312
  • Round size: Seed $3.2M–$16M; Series B $17M–$125M
  • Lead/follow: 41% lead, 59% follow
  • Last fund: Likely actively investing — fund raised in 2025

Portfolio highlights

  • Q Mixers — Q Mixers is a food and beverage company that makes carbonated mixers, beverages crafted from real ingredients.Its products are available in bars and restaurants, as well as in groceries and liquor stores. Flavors available: Ginger Beer, Tonic Water, Indian Tonic Water, Ginger Ale, Club Soda, Grapefruit, and Kola.It was established by JordanSilbert and Ben Karlin in Brooklyn, New York in 2007.
  • Dewey’s Bakery — Dewey’s Bakery has had the privilege of offering customers deliciously sweet and savory treats that reflect the local flavors we love. Our products are baked with care, and our passion is creating moments that bring people together to slow down, celebrate life and enjoy the moment. Our bakery has become a beloved part of our hometown ofWinston-Salem, NC, and we’re now proud to offer our cookies and crackers nationwide so we can continue to delight taste buds from coast to coast!
  • Celcius Logistics Solutions — India's Largest 'ONLINE " cold chain network.Book reefer vehicles, Cold Storages or get booking for your vehicle and cold storages across India instantly with the best price
Show all investments...

Sofinnova Partners
VC Fund · Paris, Ile-de-France, France · 5 investments in France Life Science startups

Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Series C
  • Geography: France, United States, United Kingdom

Investor stats

  • Total investments: 329
  • Round size: Series A $6.6M–$70M; Series B $10M–$109M; Series C $12M–$100M
  • Lead/follow: 46% lead, 54% follow
  • Last fund: Likely still investing — raised $200M in 2023

Portfolio highlights

  • Myricx Bio — Myricx Pharma is a small molecule drug discovery company engaged in developing novel proprietary inhibitors of human N-myristoyltransferases (NMT), with a primary focus in oncology but also exploring potential applications across other diseases.
  • Comet Biorefining — Comet Biorefining is a leading provider of sustainable high-quality cost-competitive cellulosic glucose technology for applications in renewable biofuels and biochemicals. The company’s proprietary technology allows for the conversion of wood, wheat straw, bagasse, corn stover and other agricultural waste materials into high purity cellulosicglucose syrup. These non-food sources offer lower cost and price stability when compared to food sugar sources such as corn or sugar cane. Demonstrated at 5 dry tons per day scale, Comet is focusing on commercial scale up and development of commercial partnerships with applications in renewables industries.
  • Forth Therapeutics — Forth Therapeutics is a biotechnology company dedicated to advancing precision treatments for fibrosis.
Show all investments...

Angels Santé
VC Fund · Puteaux, Ile-de-France, France · 4 investments in France Life Science startups

Angels Santé is the leading French Business Angel Network solely dedicated to Healthcare investments.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical Device
  • Stage:Seed, Angel
  • Geography: France, India, United States

Investor stats

  • Total investments: 37
  • Round size: Seed $1.1M–$4.6M; Angel $658k–$1.3M
  • Lead/follow: 11% lead, 89% follow

Portfolio highlights

  • Kimialys — Kimialys provides a patented and disruptive surface chemistry for biosensors, enabling the development of innovative rapid diagnostic assays.
  • StemInov — StemInov is developing a stem cell therapy for inflammatory diseases with a first focus on critical care: septic shock and ARDS
  • SeaBeLife — SeaBeLife is a biotechnology company that develops a range of drug candidates intended to block regulated necrosis (or regulated cell death of cells), from a family of patented molecules.
Show all investments...

Paca Investissement
VC Fund · Paris, Ile-de-France, France · 4 investments in France Life Science startups

Paca Investissement is specializes in investing in startups and developmental stages. The fund invests in the Provence-Alpes-Côte d'Azur (PACA) region.

Show more...

Investment focus

  • Industry: Software, Internet, Manufacturing
  • Stage:Seed, Series A
  • Geography: France

Investor stats

  • Total investments: 73
  • Round size: Seed $329k–$1.6M; Series A $411k–$9.2M
  • Lead/follow: 19% lead, 81% follow

Portfolio highlights

  • GANGZ — Gangz is the first digital platform for talent recruitment: Models, hosts, extras and actors.
  • SailEazy — The SailEazy community offers all sailing enthusiasts the choice of freedom. A shared professional fleet, bases between the Atlantic and the Mediterranean ... discover a disruptive and innovative way of navigation. Throughout the year, 7 days / 7 and 24 hours a day, you can book and discover the high-performance sailboats of a professionalfleet, entirely managed by SailEazy. Subscriber, or punctual browser, autonomous or not, you have the choice. You freely determine your niche of reservation, without constraint time or duration, you choose your base of departure and your sailboat, according to your program (short exit, cruise, regatta, coastal, wide ...). Hourly pricing includes a 360 ° service keychain beyond the cost of the lease, including insurance, fuel, cleaning and equipment. Compulsive veiled, expert or contemplative, all members of the community have their way of navigating.
  • C4Diagnostics — Dana69 adalah tempat penyedia link login game online yang bisa di mainkan dengan menggunakan smartphone android dan iphone dan bisa melakukan top up slot dana 10k atau slot deposit dana 10k selalu online 24 jam.
Show all investments...

AdBio partners
VC Fund · Paris, Ile-de-France, France · 4 investments in France Life Science startups

AdBio partners is a European Life Sciences Venture Capital firm dedicated to seeding healthcare’s step forward.We work with leading research institutions and well-established technology transfer offices, with a strong network of scientific and medical partners, exploring new territories to source breakthrough medical discoveries and driveinventive Life Sciences start-ups to success.We embrace European Life Sciences’ dynamic of innovation. Europe harbors a vibrant environment for medical and scientific investigation, with some of the most leading-edge academic and research centers. AdBio partners seizes the opportunity to highlight their undervalued research programs and assets and participate in structuring Europe’s biotechnology ecosystem.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Pharmaceutical
  • Stage:Seed, Series A, Venture - Series Unknown
  • Geography: France, Spain, Belgium

Investor stats

  • Total investments: 32
  • Round size: Seed $2.2M–$18M; Series A $18M–$37M; Venture - Series Unknown $2.2M–$16M
  • Lead/follow: 41% lead, 59% follow
  • Last fund: Likely still investing — raised $116M in 2021

Portfolio highlights

  • Orikine Bio — Orikine Bio is a pioneer biotech company in the field of tailored cytokines with unmatched biological properties for the treatment of immune-mediated disorders.
  • ARTHEx Biotech — ARTHEx Biotech S.L. is a spin-off company of the University of Valencia that is developing advanced RNA treatments against genetic diseases.
  • Integra Therapeutics — Integra Therapeutics is a developer of next generation of gene editing tools to cure diseases.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Idinvest Partners
VC Fund · Paris, Ile-de-France, France · 4 investments in France Life Science startups

Idinvest Partners is a pan-European private equity manager focused on the low and middle-market segments. With over 6 billion euros under management, the company has developed several complementary areas of expertise, including equity investments in buyout deals focusing on both mid-size as well as young innovative European companies; primaryinvestments in European private equity funds focusing primarily on the middle market segment; secondary investments; mezzanine investments in Europe; and private equity consulting.Idinvest Partners’ recent success stories include Criteo, Clear2Pay, Meetic, Prosensa, Converteam, Kwik Fit, Lastminute.com, Dailymotion, Deezer, Talend, Synthesio, Menlook, Vestiaire Collective, Pretty Simple, Curse.com, Withings, Kantox, Secret Escapes, Happn, Peakon, Dayuse, Botify, Financefox, Azalead and many more.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Series B, Series A
  • Geography: France, United States, Spain

Investor stats

  • Total investments: 254
  • Round size: Series A $3.3M–$27M; Series B $7.8M–$66M
  • Lead/follow: 35% lead, 65% follow
  • Last fund: May invest from a new fund soon — raised $88M in 2021

Portfolio highlights

  • Botify — Search engines miss about half the content on enterprise websites. Uncover those hidden opportunities with Botify, the leading enterprise SEO platform!
  • LumApps — LumApps is the only intranet packaged solution that enables employees to feel connected to their organization and engaged in their work from anywhere by delivering a modern, smart digital headquarters that empowers your employees to design a work experience that works for them.
  • Stanley Robotics — Stanley Robotics is a DeepTech business helping the transportation and logistics industries digitalise and robotise outdoor operations.
Show all investments...

XAnge
VC Fund · Paris, Ile-de-France, France · 3 investments in France Life Science startups

XAnge is a Franco-German team of venture capital investors that manages €450 million and invests in digital, deeptech, and impact startups.It is the innovation brand of the Siparex group, a major player in French private equity. XAnge is a key European investor in early-stage startups and is looking for game-changing startups and entrepreneurswho rock the code[s].The Paris, Ile-de-France-located company was founded in 2004.

Show more...

Investment focus

  • Industry: Software, SaaS, E-Commerce
  • Stage:Series A, Seed, Series B
  • Geography: France, Germany, Belgium

Investor stats

  • Total investments: 233
  • Round size: Seed $1.1M–$8M; Series A $3M–$22M; Series B $6.6M–$75M
  • Lead/follow: 31% lead, 69% follow
  • Last fund: Likely still investing — raised $234M in 2021

Portfolio highlights

  • HABX — habx provides real estate developers with a digital solution enabling the personalization of new housing units
  • ELDIM — Eldim proposes photometric and calorimetric products of instrumentation allowing to qualify the ergonomic parameters and the quality of the image of the flat screens. Its customers (manufacturers of components or sreen-Sharp, Sony, Samsung, -or integrators-IBM, Apple, Valeo, Honeywell, Nokia, Motorola-) are mainly foreigns.
  • SunaCare — SunaCare specializes in the nationwide placement of private nurses from the (adjoining) EU-countries.The company's services offer care-supporting senior care at home, enabling people to get cares from Germany and neighboring countries that provide 24-hour care on-site.
Show all investments...

Boehringer Ingelheim Venture Fund
VC Fund · Ingelheim Am Rhein, Rheinland-Pfalz, Germany · 3 investments in France Life Science startups

Discover Boehringer Ingelheim Venture Fund. We invest in groundbreaking science to transform care. Explore our mission and join us in advancing medicine

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Seed
  • Geography: United States, Germany, Switzerland

Investor stats

  • Total investments: 104
  • Round size: Seed $1.8M–$20M; Series A $3.8M–$34M; Series B $11M–$50M
  • Lead/follow: 47% lead, 53% follow
  • Last fund: May invest from a new fund soon — raised $250M in 2018

Portfolio highlights

  • Tacalyx — Tacalyx develops therapeutics targeting cancer-specific carbohydrate antigens on the surface of metastatic malignant tumors where no satisfactory treatments exist.The name Tacalyx is derived from TACA (Tumor Associated Carbohydrate Antigen) and ‘lyx’ from the term Glycocalyx, the glycan-containing layer covering cells. Cancer cells differ fromnormal cells by displaying aberrant carbohydrate structures on their surfaces promoting metastasis, angiogenesis or suppression of the immune system. TACAs result from the aberrant glycosylation that is seen with transformation to a tumor cell and represent attractive targets for cancer treatment since they are displayed with high cancer specificity and enhance tumor virulence via the mentioned diverse mechanisms.
  • smartbax — We develop novel multi-targeted, antibacterial compounds with extraordinary potency against multi-drug resistant bacteria and difficult-to-treat biofilms.
  • Rinri Therapeutics — Rinri Therapeutics has been founded on pioneering research into auditory stem cells led by Professor Marcelo Rivolta at the University of Sheffield.
Show all investments...

Karista
VC Fund · Paris, Ile-de-France, France · 3 investments in France Life Science startups

Karista is an early-stage venture capital firm created in 2001 investing in Health, Digital, Tech, and NewSpace.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Health Care
  • Stage:Seed, Series A, Series B
  • Geography: France, United States, Finland

Investor stats

  • Total investments: 156
  • Round size: Seed $713k–$6.3M; Series A $1.2M–$18M; Series B $2.5M–$33M
  • Lead/follow: 19% lead, 81% follow

Portfolio highlights

  • Tricares — TRiCares is a medical device company, devoted to developing a catheter-based valve replacement system for minimal invasive treatment of tricuspid valve regurgitation.
  • Advestigo — Advestigo S.A., a technology company, provides digital assets protection solutions. It offers theraography technology, which analyses digital content to generate content-based fingerprints; AdvestiCHECK, a software package that allows companies to monitor information technology networks and workstations; and AdvestiGUARD, a software package thatallows companies to monitor communication channels. The company was founded in 2002 and is based in Saint-Cloud, France. As of March 9, 2009, Advestigo S.A. operates as a subsidiary of Hologram Industries SA.
  • Physikron — Physikron is a developer of mass spectrometry technologies used to improve the performance of tandem spectrometry. Its technologies offer proteomic analysis and dramatically improves the number of peptides and proteins identified during an LC/MS/MS acquisition that enable researchers to research in an enhanced way.
Show all investments...

Galia Gestion
VC Fund · Bordeaux, Aquitaine, France · 3 investments in France Life Science startups

Galia Gestion is a private equity and venture capital firm. GALIA Gestion is a “management company” approved by the AMF, with majority shareholder Alliance Entreprendre.

Show more...

Investment focus

  • Industry: Software, Manufacturing, Biotechnology
  • Stage:Series A, Seed
  • Geography: France, United States

Investor stats

  • Total investments: 55
  • Round size: Seed $531k–$2.9M; Series A $849k–$6.9M
  • Lead/follow: 24% lead, 76% follow
  • Last fund: May invest from a new fund soon — raised $21M in 2013

Portfolio highlights

  • Wizaly — Wizaly's ambition is to help advertisers understand the impact of their online & offline marketing channels across all conversions, helping clients improve the ROI of their marketing budgets by up to 30%.The Wizaly platform applies its algorithmic attribution technology to provide a holistic and unbiased vision of campaigns performancestogether with actionable optimization recommendations.
  • Agenium — Agenium offers career perspectives in an international and tech environment. They offer this through the specific expertise of their business units. They offer solutions to the business and of the defense, industry, and space sectors.
  • Mon Chasseur Immo — Mon Chasseur Immo is a Real Estate, based in Languedoc Roussillon.
Show all investments...

Blue Horizon Corporation
VC Fund · Zürich, Zurich, Switzerland · 3 investments in France Life Science startups

Blue Horizon is accelerating the transition to a sustainable food system that delivers outstanding returns for the planet and people.

Show more...

Investment focus

  • Industry: Food and Beverage, Food Processing, Biotechnology
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United States, United Kingdom, Germany

Investor stats

  • Total investments: 98
  • Round size: Seed $2M–$12M; Pre-Seed $450k–$6.3M; Series A $2M–$40M
  • Lead/follow: 31% lead, 69% follow
  • Last fund: May invest from a new fund soon — raised $187M in 2021

Portfolio highlights

  • WOW EARN — Discover WOW EARN, the all-in-one Web3 app with crypto mining, multi-chain wallet, staking NFTs, and marketplace dApps. Join the global Web3 community today.
  • EV Biotech — We design and optimise your precision fermentation strains and processes, tailored to your success.
  • foodforecast — AI supported solution to reduce food waste.
Show all investments...

Advent Life Sciences
VC Fund · London, England, United Kingdom · 3 investments in France Life Science startups

Advent Life Sciences is a venture team investing in life sciences businesses. The team consists of 11 professionals with extensive scientific, medical and operational experience, and a long-standing track record of entrepreneurial and investment success across the UK, Europe and the US. The Firm invests in a range of sectors within life sciences,principally in new drug discovery, enabling technologies, and med tech. Realizations in the last three years include Algeta, Avila, CN Creative, EUSA, Micromet. Current investments include Acutus, Biocartis, Cellnovo, f2G, NeRRe,

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B
  • Geography: United States, United Kingdom, France

Investor stats

  • Total investments: 71
  • Round size: Series A $5.5M–$51M; Series B $21M–$97M
  • Lead/follow: 35% lead, 65% follow
  • Last fund: May invest from a new fund soon — last raise in 2021

Portfolio highlights

  • Cyted — Cyted focuses on providing digital diagnostic infrastructure to drive the earlier detection of disease. Our technologies use AI and novel biomarkers to improve patient outcomes.
  • Glycomine — We are developing a PMM2-CDG substrate replacement therapy. GLM101 is a mannose-1 phosphate treatment.
  • Beacon Therapeutics — Beacon aids in restoring and improving the vision of patients with ophthalmic gene therapy. Find out more.
Show all investments...

Partech
VC Fund · Paris, Ile-de-France, France · 2 investments in France Life Science startups

Partech is a global venture capital firm with offices in San Francisco, Paris, Berlin and Dakar. Partech invests in Internet and information technology startups at seed, venture and growth stages.

Show more...

Investment focus

  • Industry: Software, E-Commerce, SaaS
  • Stage:Series A, Seed, Series B
  • Geography: United States, France, Germany

Investor stats

  • Total investments: 559
  • Round size: Seed $1.1M–$10M; Series A $4.2M–$28M; Series B $9M–$55M
  • Lead/follow: 34% lead, 66% follow
  • Last fund: Likely still investing — fund raised in 2024

Portfolio highlights

  • Prysm Systems — An interactive video wall is a powerful digital display option that sees your message. touch screen display designed for application commercial grade retail.
  • EcoVadis — Ratings platform to assess corporate social responsibility and sustainable procurement. Solutions include risk monitoring, audit management and sustainability ratings.
  • Brevo — Brevo is a developer of a cloud-based digital marketing platform used to meet the demand of businesses to engage with customers. Its platform encompasses the entire chain, from the creation of a newsletter to analysis and reporting tools to targeting modules that enable businesses, eCommerce sellers, and agencies to build customer relationshipsthrough digital marketing campaigns, transactional messaging, and marketing automation.Unlike other marketing solutions built for enterprise-level budgets and expertise, Sendinblue tailors its all-in-one suite to suit the marketing needs of growing SMBs in tough markets.The company was founded in 2012 and is headquartered in Paris, France.
Show all investments...

WiSEED
VC Fund · Toulouse, Midi-Pyrenees, France · 2 investments in France Life Science startups

Wiseed is a crowdfunding platform that enables its users to invest in SMEs and enterprises. The platform offers investments for startups, real-estate firms, social innovation and renewable energy projects, and agriculture firms. It was founded in 2008 by Nicolas Seres and Thomas Merquiol and is based in Toulouse.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Manufacturing
  • Stage:Seed, Series A
  • Geography: France, Norway

Investor stats

  • Total investments: 33
  • Round size: Seed $384k–$3.3M; Series A $1.2M–$7.8M
  • Lead/follow: 30% lead, 70% follow

Portfolio highlights

  • Aéronde — The Aéronde is an innovative electric airship with a toroidal shape (giant donut) of 15 meters in diameter, designed to offer a silent, energy-efficient flight with very low environmental impact. Inflated with approximately 400 m³ of helium, it can carry up to two people and equipment, with a payload of 200 kg .
  • Vaxinano — Vaxinano is a biotechnology company specialized in preclinical and pharmaceutical development of human and veterinary vaccines and drug delivery systems. Vaxinano was created in 2016, building on 25 years of research and clinical trials on vaccines and the patented technology of Pr Didier Betbeder.
  • BiPER Therapeutics — BiPER Therapeutics is a biotech company to develop and commercializes novel therapeutics.
Show all investments...

Bertrand Jacquelot
Angel · Paris, Ile-de-France, France · 2 investments in France Life Science startups

Bertrand Jacquelot is the Founding President of Projim. He attended the University of Marne-la-Vallee.

Show more...

Investment focus

  • Industry: Food and Beverage, E-Commerce, Information Technology
  • Stage:Pre-Seed, Seed, Angel
  • Geography: France, United States

Investor stats

  • Total investments: 20
  • Round size: Seed $1.5M–$7.8M; Pre-Seed $120k–$1.1M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Bolk — Bolk provides autonomous bowl-making robotic canteen which producing warm meals, cold dishes and desserts from precooked ingredients.
  • Arkania — B2B API solution for brands to create and sell online NFTs directly on their platforms
  • Starton — Integrate blockchain technology this week. Focus on your vision, we handle blockchain complexity
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Beyond Impact
VC Fund · Minneapolis, Minnesota, United States · 2 investments in France Life Science startups

Beyond Impact is your trusted Managed Service Provider (MSP), delivering tailored IT solutions like managed IT services, cybersecurity, cloud computing, IT help desk support, and data backup. Our expert team aligns your IT with business goals, providing proactive monitoring and network security. Contact us today to streamline your IT operations for a secure, agile, and future-ready business. Beyond Impact: Empowering your IT success.

Show more...

Investment focus

  • Industry: Food and Beverage, Food Processing, Alternative Protein
  • Stage:Seed, Series A, Pre-Seed
  • Geography: France, Canada, Singapore

Investor stats

  • Total investments: 9
  • Round size: Seed $670k–$10M; Series A $13M–$48M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • GOURMEY — We create sustainable cultivated meat delights for an uncompromising and conscious generation.
  • Nowadays — The Nowadays nugget is made with just 7 simple, plant-based ingredients.
  • OLALA! — Seafood Reboot's ambition is to promote worldwide best-in-class Fish substitutes from micro-algae for natural, healthy, sustainable food and to preserve marine wildlife.
Show all investments...

Social Starts
VC Fund · San Francisco, California, United States · 2 investments in France Life Science startups

Social Starts is a $60M+ venture capital partnership with a uniquely data-driven approach to investing in moment-of-inception and Series A financing rounds.

Show more...

Investment focus

  • Industry: Software, Health Care, Artificial Intelligence
  • Stage:Seed, Series A
  • Geography: United States, Germany, Canada

Investor stats

  • Total investments: 301
  • Round size: Seed $100k–$3.7M; Series A $3.2M–$15M
  • Lead/follow: 1% lead, 99% follow

Portfolio highlights

  • Funnel — Our revolutionary CRM property management software saves both time and money for agents and owners while making leasing more efficient.
  • Original Stitch — PLATINUMTOTO hadir sebagai situs togel macau di Indonesia yang sangat populer di kalangan togelers platinumtoto dengan jackpot 4D setiap hari nya
  • Bark Technologies — Learn how Bark's parental controls can help you protect your kids online and in real life with monitoring, screen time controls, and more.
Show all investments...

Andrew Nutter
Angel · Paris, Ile-de-France, France · 2 investments in France Life Science startups

Andrew Nutter is a Co-Founder at Gama. He attended Stanford University.

Show more...

Investment focus

  • Industry: Software, SaaS, FinTech
  • Stage:Seed, Pre-Seed, Series A
  • Geography: France, United Kingdom, United States

Investor stats

  • Total investments: 25
  • Round size: Seed $550k–$4.9M; Pre-Seed $809k–$3.4M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Yavin — Yavin provides modern point-of-sale solutions for European merchants. Yavin is a tool to receive payments, sell smarter, and grow the business.
  • Gama — Thanks to cheap, reliable and scalable solar sails, we are redefining deep space access.
  • EV Biotech — We design and optimise your precision fermentation strains and processes, tailored to your success.
Show all investments...

Invus
VC Fund · New York, New York, United States · 2 investments in France Life Science startups

Invus recognizes that every company is unique and that extraordinary business performance cannot be achieved by following a formulaic approach. Due to their unique structure, they have a great deal of flexibility in the types of companies and situations where they can get involved.They know that real transformation takes time and that it is nevera straight line. They fully align their incentives with their partners and have the wherewithal and long-term commitment to see through any bumps along the way.They have been successfully empowering owner-managers since 1985. They have been reinvesting the same pool of money from the same group of European families (through their Artal investment vehicle) since their founding. Today they manage over $4 billion in an evergreen fund and work out of offices in New York, London, Paris and Hong Kong.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series B, Series C, Series A
  • Geography: United States, France, China

Investor stats

  • Total investments: 284
  • Round size: Series A $14M–$200M; Series B $35M–$230M; Series C $31M–$165M
  • Lead/follow: 17% lead, 83% follow

Portfolio highlights

  • Aive — Turn 1 master into unlimited, brand-controlled versions. Automate post-production, scale your output, and take back control of video performance.
  • Thrive Market — Thrive Market has everything you need to stock your pantry with organic, high-quality products. Shop food, bath and beauty, baby, and home goods here.
  • Zero Motorcycles — Manufacturer of 100% electric motorcycles for the street and dirt
Show all investments...

European Commission
VC Fund · Brussels, Brussels Hoofdstedelijk Gewest, Belgium · 2 investments in France Life Science startups, 44 in the past 12 months

The official website of the European Commission, providing access to information about its political priorities, policies and services

Show more...

Investment focus

  • Industry: Software, Biotechnology, Health Care
  • Stage:Grant, Seed, Pre-Seed
  • Geography: France, Spain, Germany

Investor stats

  • Total investments: 290
  • Round size: Seed $117k–$10M; Grant $117k–$74M; Pre-Seed $55k–$5.4M
  • Lead/follow: 68% lead, 32% follow
  • Last fund: May invest from a new fund soon — last raise in 2014

Portfolio highlights

  • EU-CONEXUS — European University for Smart Urban Coastal Sustainability
  • Leonardo — Leader in Aerospace, Defence & Security
  • Egyptian Electricity Transmission Company — Egyptian Electricity Transmission Company manages, operates, and maintains high-voltage electricity grids. It acts purely as a utility infrastructure operator to transmit bulk power from power plants to regional distribution networks.
Show all investments...

Bernard Majoie
Angel · Brussels, Brussels Hoofdstedelijk Gewest, Belgium · 2 investments in France Life Science startups

Bernard Majoie - President @ Fournier-Majoie

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Health Care
  • Stage:Seed, Pre-Seed, Series A
  • Geography: France, Belgium

Investor stats

  • Total investments: 6
  • Round size: Seed $1.3M–$2.7M
  • Lead/follow: 33% lead, 67% follow

Portfolio highlights

  • reMYND — Driving the development of disease-modifying treatments
  • AgenT — AgenT develops the first blood diagnosis to detect Alzheimer's years before the onset of the irreversible symptoms.
  • PEP-Therapy — PEP-Therapy is a French biotechnology company developing first-in-class peptides as targeted therapies in oncology
Show all investments...

AQUITI Gestion
VC Fund · Bordeaux, Aquitaine, France · 2 investments in France Life Science startups

Floated in 1998, thanks to the local authority "Conseil Régional d’Aquitaine" and the "Caisse des dépôts", our venture, growth and LBO funds (Aquitaine Amorçage, ACI, Aqui-Invest) now benefit from the support of public and private influential shareholders and sponsors.Up to now, AQUITI GESTION has invested in more than 200operations contributing to the creation and development of about 150 companies and thousands of jobs.Currently, ACI and Aqui-Invest manage a portfolio gathering 50 companies which revenues scale from 0 € (early stage) to 30 M€.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Manufacturing
  • Stage:Series A, Seed
  • Geography: France, United States

Investor stats

  • Total investments: 59
  • Round size: Seed $170k–$4.1M; Series A $849k–$18M
  • Lead/follow: 24% lead, 76% follow
  • Last fund: May invest from a new fund soon — raised $6.4M in 2010

Portfolio highlights

  • Synboli — Synboli is a deep-tech company that combines artificial intelligence and proprietary chemistry technologies to accelerate the discovery and development of novel polymers and advanced materials. Its AI-powered platform predicts polymer properties, designs new molecular structures, and integrates laboratory testing to reduce material developmenttimelines.
  • Aquassay — Aquassay assists you with improving the industrial and environmental performance of all your water usage (supply, production, discharge).
  • CardNexus — CardNexus provides a digital platform for managing, trading, and selling trading card collections.
Show all investments...

Entrepreneurs First
VC Fund · London, England, United Kingdom · 2 investments in France Life Science startups

We turn exceptional individuals into funded founders. We back you first, then give you a bridge to Silicon Valley.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Information Technology
  • Stage:Pre-Seed, Seed, Series A
  • Geography: United Kingdom, United States, India

Investor stats

  • Total investments: 283
  • Round size: Seed $724k–$7M; Pre-Seed $55k–$3.1M; Series A $6M–$45M
  • Lead/follow: 20% lead, 80% follow

Portfolio highlights

  • Juno Bio — Disrupted vaginal microbiomes can cause everything from recurrent infections to infertility. Get your comprehensive vaginal microbiome test and find out where you stand.
  • Sourcepulse — Your early warning system for software delivery (YC S23)
  • EverSettled — Navigate the probate process with confidence. We provide a free checklist, guidance, and support to help families find clarity in the chaos of loss.
Show all investments...

Kinled Holding
VC Fund · New York, New York, United States · 2 investments in France Life Science startups

Kinled was founded in 1980 to retain the investment assets of the Aisher family.In 1990, the investment focus shifted to a portfolio of early stage investments applying Kinled’s company development experience alongside the endurance and passion of family owned investments together with the strategic focus of venture capitalists.Since then,Kinled has taken 8 companies to public markets and many more to successful trade sales at significant multiples.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States, Switzerland

Investor stats

  • Total investments: 139
  • Round size: Seed $594k–$14M; Series A $1.7M–$40M
  • Lead/follow: 4% lead, 96% follow

Portfolio highlights

  • Esper — Esper is the first cloud-based platform to help governments proactively manage public policy with better data and transparency.
  • Varda — Expanding the economic bounds of humankind with the world's first orbital manufacturing & reentry platform.
  • TAG Therapeutics — TAG Therapeutics develops precision medicine approaches for telomere pathologies and aging-related diseases, such as Idiopathic Pulmonary Fibrosis and Short Telomere Syndromes
Show all investments...

Eutopia VC
VC Fund · Paris, Ile-de-France, France · 2 investments in France Life Science startups

Eutopia is a fund for consumer startups. We back founders who are rethinking the way we eat, shop, sleep and feel. We are backing 26 startups

Show more...

Investment focus

  • Industry: E-Commerce, Retail, Food and Beverage
  • Stage:Seed, Series A, Venture - Series Unknown
  • Geography: France, Belgium, Denmark

Investor stats

  • Total investments: 16
  • Round size: Seed $3.3M–$10M; Series A $4M–$48M; Venture - Series Unknown $1.3M–$8M
  • Lead/follow: 44% lead, 56% follow
  • Last fund: May invest from a new fund soon — last raise in 2019

Portfolio highlights

  • Bastille — Bastille is a brand of urban bicycles. The Astir brand is synonymous with folding bicycles. The primary quality constraint Bastille, a British designer, aims to create a folding motorcycle with standard wheels rather than the mini 16-inch wheels that are traditionally associated with folding bikes.
  • Moderato — Moderato is a retail and wholesale company that manufactures and supplies a range of beverages online to various sectors.
  • SPRiNG Collective — SPRiNG is a consumer goods company that offers clean and efficient laundry and cleaning products, delivered in a 100% plastic-free box and directly in the mailbox. The company is headquartered in Paris, Ile-de-France, France by Philippe Cantet, Laure Favre, and Ben Guerville in 2017.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Sofimac Investment Managers
VC Fund · Clermont-ferrand, Auvergne, France · 2 investments in France Life Science startups

Acteur incontournable du capital risque de proximité, SOFIMAC PARTNERS accompagne depuis maintenant plus de 30 ans les PME régionales dans le financement de leur développement à moyen / long terme. Répondant à la problématique de sous capitalisation des PME françaises, SOFIMAC PARTNERS intervient en fonds propres aux côtés des chefsd’entreprises quelle que soit leur problématique : Création, Développement, Transmission. Gérant 200 M€ d’actifs au travers de 16 fonds (FCPR, FCPI, SCR, FIP,…), notre groupe réalise ses investissements sur une grande variété de secteurs, couvrant aussi bien les activités traditionnelles que technologiques (chimie verte, éolien, chaudronnerie aéronautique, e-commerce, édition de logiciel, médecine nucléaire etc…)

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Manufacturing
  • Stage:Seed, Series A
  • Geography: France, Italy, Austria

Investor stats

  • Total investments: 73
  • Round size: Seed $274k–$2.2M; Series A $1.6M–$15M
  • Lead/follow: 11% lead, 89% follow

Portfolio highlights

  • Ultrawatt — Ultrawatt is a mission-driven startup to improve urban architecture while making a beneficial social and environmental effect.
  • Mob-Energy — Mob-Energy is a privately held company specializing in the development of mobile and innovative charging solutions. It designs autonomous charging robots capable of moving energy where it is needed, optimizing the site's existing infrastructure. The company was founded in 2018 and is headquartered in Villeurbanne, Auvergne-Rhône-Alpes.
  • Snowleader — Votre boutique en ligne (qui sent bon le reblochon) spécialiste des sports d’hiver, outdoor et street.
Show all investments...

Point Nine
VC Fund · Berlin, Berlin, Germany · 2 investments in France Life Science startups

Point Nine Capital is a Berlin-based venture capital firm focused exclusively on early-stage Internet investments in areas like Software-as-a-Service (SaaS), online marketplaces, and mobile.The fund and its managers, Pawel Chudzinski and Christoph Janz have backed a number of highly successful Internet companies such as Delivery Hero, Clio,Shiftplanning, Vend, Typeform, and Zendesk from their earliest stages.

Show more...

Investment focus

  • Industry: Software, SaaS, Internet
  • Stage:Seed, Series A, Series B
  • Geography: Germany, United States, France

Investor stats

  • Total investments: 265
  • Round size: Seed $900k–$7.7M; Series A $3.2M–$24M; Series B $10M–$62M
  • Lead/follow: 35% lead, 65% follow

Portfolio highlights

  • Sereact — The only real-world verified Vision-Language-Action AI. Proven at scale. Trained on the world's largest dataset of robotic picks.
  • Delivery Hero — Delivery Hero is the world's leading local delivery company. We are on a mission to deliver an amazing experience - fast, easy, and to your door.
  • Polar Analytics — Your Shopify Analytics. Effortless. Centralized. Smart. Connect your datasource in one clic, automatically calculate KPIs. Visualize them all in one place. Get alerts and recommendations in realtime
Show all investments...

Lundbeckfonden Ventures
VC Fund · Copenhagen, Hovedstaden, Denmark · 2 investments in France Life Science startups

Lundbeckfond Ventures is an evergreen life science venture fund established in the autumn of 2009 and wholly owned by the Lundbeck Foundation. The structure as an evergreen fund allows flexibility in the investment approach and the possibility, when appropriate, to take a long-term perspective in the investments. On an annual basis, LundbeckfondVentures invests up to € 50 million.Lundbeckfond Ventures is a financially driven venture fund generating returns to support the group's activities and operating independently from the Lundbeck Foundation’s controlling ownerships in H. Lundbeck A/S, ALK-Abelló and Falck.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series B, Series A, Series C
  • Geography: United States, Denmark, United Kingdom

Investor stats

  • Total investments: 70
  • Round size: Series A $10M–$50M; Series B $20M–$95M; Series C $16M–$53M
  • Lead/follow: 33% lead, 67% follow

Portfolio highlights

  • Kvantify — Quantum computing will revolutionize many aspects of computing. We can help your business harness the full potential of Quantum Computing and High-Performance Computing today.
  • SNIPR Biome — We are the CRISPR Microbiome Company; Our mission is to develop CRISPR-based medicines that give hope for effective and safe treatment of difficult-to-treat diseases in the future.
  • Women in Life Science Denmark — WiLD is a networking platform for women in senior positions in business and academia that is motivating and focused on science.
Show all investments...

IRDI SORIDEC Gestion
VC Fund · Toulouse, Midi-Pyrenees, France · 2 investments in France Life Science startups

IRDI SORIDEC Gestion is a portfolio management company that supports startups, SMEs, and ETIs in the greater South-West of France with equity capital at all stages of development.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Medical
  • Stage:Seed, Series A
  • Geography: France, Brazil, Singapore

Investor stats

  • Total investments: 54
  • Round size: Seed $1.6M–$5.8M; Series A $3.7M–$13M
  • Lead/follow: 24% lead, 76% follow

Portfolio highlights

  • Donecle — Automated aircraft inspections by drone for airlines and MRO. Donecle makes aircraft maintenance faster, safer and more reliable. Our unique technology combines 100% automated drone and image analysis algorithms to detect defects, lightning strikes, evaluate paint wear and check placards.
  • Nepting — NEPTING is a company specializing in payment solutions and services with the main objective of supporting business in its evolution. Listening to its customers, it brings a skill, a culture, an innovative offer for all existing, emerging and future payment methods.NEPTING equips all types of points of acceptance with its multi-channel andmulti-vendor electronic payment system and its secure solutions in compliance with the standards in force. It is distinguished by its ability to give its customers the many advantages of a single and homogeneous offer for all its sales channels: mPOS, Retail, TPE, Automate, e-commerce ...
  • ThIA Santé Mentale
Show all investments...

Alexandria Venture Investments
VC Fund · Pasadena, California, United States · 2 investments in France Life Science startups, 18 in the past 12 months

Alexandria Venture Investments is a venture capital firm that develops work in real estate technology, and healthcare sectors. The company's strategic venture capital platform is Alexandria Venture Investments. Since its inception in 1996, the company has invested in disruptive life science, agrifood tech, and technology companies that aredeveloping transformative new modalities and platforms to meaningfully improve human health.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Seed
  • Geography: United States, Canada, France

Investor stats

  • Total investments: 270
  • Round size: Seed $2M–$31M; Series A $12M–$100M; Series B $25M–$150M
  • Lead/follow: 7% lead, 93% follow

Portfolio highlights

  • Triveni Bio — Triveni Bio is at the forefront of human genetics, cutting-edge antibody design, and precision medicine, pioneering the identification of new disease targets.
  • Vedana Therapeutics — Vedana Therapeutics is a Seattle biotechnology company developing next-generation antibody therapies for migraine prevention.
  • CREATE Medicines — Myeloid Therapeutics is an immunology company focused on combining immunologic insights with cutting-edge technologies to harness myeloid cells to eradicate cancer and other diseases. The Company's ATAKTM platform technology can be broadly applied, and it is initially advancing a cell therapy program for T cell lymphoma and a primed monocyteapproach to treat glioblastoma. The ATAK platform is scalable to multiple treatment modalities and other disease areas in collaboration with partners.
Show all investments...

JDRF T1D Fund
VC Fund · Boston, Massachusetts, United States · 2 investments in France Life Science startups

The JDRF T1D Fund (www.t1dfund.org) is a venture philanthropy fund exclusively devoted to finding and funding the best early-stage T1D commercial opportunities to accelerate the delivery of treatments, preventions, and cures to patients. It was created to solve a critical funding gap in the T1D drug and device development pipeline. Throughpartnerships with private capital, including venture capital, pharma and foundations, the T1D Fund anticipates that it will be able to attract substantially more private investment to the T1D field than occurs today. The T1D Fund will initially focus on artificial pancreas systems, metabolic control, beta cell replacement, prevention, and beta cell restoration therapies, with an exclusive priority on the best commercial opportunities. The T1D Fund will reinvest any realized gains into new investments to further its mission.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B
  • Geography: United States, Canada, France

Investor stats

  • Total investments: 55
  • Round size: Series A $7M–$105M; Series B $18M–$130M
  • Lead/follow: 24% lead, 76% follow

Portfolio highlights

  • Diasome Pharmaceuticals — Realizing a new life with diabetes.
  • Zag Bio — Zag Bio is harnessing the immune system in a whole new way by targeting the thymus to change treatment possibilities for millions of patients with autoimmune diseases.
  • Tetragenetics — Our protein production platform provides recombinant transmembane proteins, including ion channels and GPCRs, for antibody drug discovery
Show all investments...

Air Street Capital
VC Fund · London, England, United Kingdom · 2 investments in France Life Science startups

Air Street Capital provides venture capital funding and strategic support focused on early-stage companies that develop products based on artificial intelligence. It invests primarily at pre-seed, seed, and Series A stages in firms working on AI-first technology, software infrastructure, machine-learning tools, and AI-enabled life scienceapplications. The firm pairs capital investment with advisory input on product, market, and technology strategy, and facilitates connections to its broader network of AI and technology stakeholders. Air Street Capital also shares industry insights through publications and community initiatives aimed at supporting AI and related tech ecosystems.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Biotechnology
  • Stage:Seed, Series A, Series B
  • Geography: United States, United Kingdom, France

Investor stats

  • Total investments: 48
  • Round size: Seed $2.6M–$14M; Series A $14M–$48M; Series B $64M–$300M
  • Lead/follow: 27% lead, 73% follow
  • Last fund: Likely still investing — fund raised in 2023

Portfolio highlights

  • STARK — EUROPEAN DEFENCE SOVEREIGNTY
  • Profluent Bio — Profluent Bio is an AI-first protein design company that designs novel, optimal proteins that bypass existing barriers in industry.
  • Macrodata Labs — Reviewing and annotating robotics data by hand does not scale. Macrodata Labs automates QA, subtask annotation, 3D hand tracking, and reward scoring across large robot and egocentric datasets. Send a few sample episodes for a free demo.
Show all investments...

Thia Ventures
VC Fund · Genève, Geneve, Switzerland · 2 investments in France Life Science startups

WE ARE AN EARLY-STAGE INVESTOR IN ONE OF THE MOST DYNAMIC AND ESSENTIAL FIELDS OF CURRENT HUMAN ENDEAVOR WE BRING ROBUST INVESTOR MUSCLE TO EARLY-STAGE VENTURES INVESTOR A specialized and focused investor Resources Powerful industry, substance and business resources Experience Wide networks and longstanding experience Team Yet, adaptability and speed of a lean, self-financed team

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Manufacturing
  • Stage:Series A, Seed, Pre-Seed
  • Geography: United States, France, Denmark

Investor stats

  • Total investments: 22
  • Round size: Seed $3.4M–$20M; Series A $6.8M–$48M
  • Lead/follow: 14% lead, 86% follow

Portfolio highlights

  • EvodiaBio — EvodiaBio is a bio-industrial firm that creates natural, sustainable scents for the food and beverage industries. Founded in 2021 and is based in Copenhagen, Capital Region.
  • uFraction8 — Multi-award-winning, innovative, microfluidics-based filter systems to provide bio-manufacturers with energy-efficient & ultra-scalable bioprocessing systems.
  • Switch Bioworks — Switch Bioworks engineers symbiotic microbes to produce sustainable nitrogen fertilizer under the control of precise genetic circuits.
Show all investments...

Heartcore Capital
VC Fund · Copenhagen, Hovedstaden, Denmark · 2 investments in France Life Science startups

Heartcore Capital invests in companies re-enchanting the world through technology.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, FinTech
  • Stage:Seed, Series A, Series B
  • Geography: Denmark, United States, Germany

Investor stats

  • Total investments: 206
  • Round size: Seed $1.3M–$12M; Series A $3.4M–$27M; Series B $9.6M–$58M
  • Lead/follow: 27% lead, 73% follow
  • Last fund: Likely still investing — raised $250M in 2021

Portfolio highlights

  • PhaseTree — Materials design simulation company - PhaseTree ApS
  • TrapLight Games — A hard-hitting mobile game studio from Finland. Traplight is a premium mobile games studio with 10+ years of game development expertise at the highest level. Our ambition is to create world class, chart topping, scalable game services.
  • Fast Travel Games — Fast Travel Games is a VR exclusive game developer and publisher, founded by industry leading veterans and behind acclaimed titles such as Apex Construct and Wraith: The Oblivion - Afterlife.
Show all investments...

Horizons Ventures
VC Fund · Hong Kong, Hong Kong Island, Hong Kong · 2 investments in France Life Science startups

Investing in the deep science and technology that can propel humanity towards a radically better future.

Show more...

Investment focus

  • Industry: Biotechnology, Software, Artificial Intelligence
  • Stage:Series A, Series B, Seed
  • Geography: United States, United Kingdom, Canada

Investor stats

  • Total investments: 274
  • Round size: Seed $1M–$11M; Series A $6.2M–$47M; Series B $10M–$110M
  • Lead/follow: 42% lead, 58% follow

Portfolio highlights

  • Onavo — Onavo, founded 2010, is the company behind Onavo Insights, the largest mobile intelligence service, and the developer of the award-winning Onavo mobile utility apps.Onavo Insights market intelligence data, powered by fully anonymized data from Onavo's apps, powers business decisions in companies in verticals diverse as finance, gaming,entertainment and social networking, and reports are cited regularly in the press as the primary barometer of the mobile app ecosystem.
  • Magisto — Magisto online video editor is a fast & powerful video maker. Turn your photos and video clips into video stories with Magisto movie editor. Start free!
  • Corephotonics — Corephotonics is the pioneer and worldwide market leader of dual camera technologies for smartphones and mobile devices, providing a perfect mobile camera photography experience, novel photography features and superior image quality
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Siparex Groupe
VC Fund · Paris, Ile-de-France, France · 2 investments in France Life Science startups

Siparex, France,s first multi-sectoral private equity investment company, is founded in Lyon.It was a start-up at a time when the spirit of enterprise was flagging. It emerged in one of France's regions, listed the shares of the original company one of its main vehicles on the stock market, grew internationally, and has become one of theindependent groups in its line of business in the space of 30 years.

Show more...

Investment focus

  • Industry: Manufacturing, Software, Information Technology
  • Stage:Private Equity, Seed
  • Geography: France, United States, Italy

Investor stats

  • Total investments: 125
  • Round size: Seed $658k–$6.4M; Private Equity $6M–$27M
  • Lead/follow: 19% lead, 81% follow
  • Last fund: Likely still investing — raised $500M in 2021

Portfolio highlights

  • Cofarco — Official COFARCO twitter account. Commodity finance and trade credit insurance specialist.
  • DESTIA Group — DESTIA Group is a provider of personal services to different aged people.
  • Ekoscan Integrity — Ekoscan Integrity is an innovative solution for the integrity and sustainability of industrial products through the implementation of innovative technology.
Show all investments...

Wendel Growth
VC Fund · 2 investments in France Life Science startups

Wendel Growth is an investment arm of Wendel.

Show more...

Investment focus

  • Industry: Analytics, Open Source, Biotechnology
  • Stage:Series A, Venture - Series Unknown
  • Geography: France, Luxembourg

Investor stats

  • Total investments: 6
  • Round size: Series A $33M–$38M; Venture - Series Unknown $16M–$16M
  • Lead/follow: 50% lead, 50% follow

Portfolio highlights

  • AQEMIA — Aqemia is an in silico drug discovery start-up, whose ambition is to discover rapidly more innovative therapeutic molecules with better chances of success.
  • TaDaweb — Tadaweb is the first small data platform to scale Open Source intelligence for discovering and analysing information on the Internet.
Show all investments...

Polytechnique Ventures
VC Fund · Paris, Ile-de-France, France · 2 investments in France Life Science startups

Polytechnique Ventures support entrepreneurs from the School's ecosystem.

Show more...

Investment focus

  • Industry: Biotechnology, Robotics, Information Technology
  • Stage:Seed, Series A, Pre-Seed
  • Geography: France, United Kingdom, Germany

Investor stats

  • Total investments: 26
  • Round size: Seed $2M–$11M; Pre-Seed $1.3M–$2.7M; Series A $6.5M–$17M
  • Lead/follow: 35% lead, 65% follow
  • Last fund: Likely still investing — fund raised in 2023

Portfolio highlights

  • Porelio — Porelio is an environmental technology that provides purification technologies for water and industrial chemicals.
  • Goodvest — Goodvest is an investment app (life insurance) that builds a better world, in line with your values and promoting performance.
  • Jimmy — Jimmy develops and operates thermal generators that supply industrial facilities with process heat produced through nuclear fission. The company designs compact generators that use high-temperature reactor technology to create heat without combustion and deliver it to industrial systems through heat transfer circuits. Its systems connect to factoryinfrastructure and provide heat for processes such as steam production, thermal oil heating, or hot air generation. Jimmy installs, operates, and manages these generators as integrated energy units adapted to the heat demand of each industrial site. The technology relies on micro-reactor architecture and modular deployment so multiple units can be combined to match required thermal output. Through this approach, Jimmy provides industrial heat that replaces fossil-fuel-based heat sources in manufacturing and processing operations.
Show all investments...

Sylvain Zimmer
Angel · Paris, Ile-de-France, France · 2 investments in France Life Science startups

Sylvain Zimmer is based out of Paris, Ile-de-France and is the Chief Technology Officer of La Suite territoriale (EIG) of Direction interministérielle du numérique. Sylvain previously worked at Contentsquare as a head of the CTO office. Sylvain Zimmer attended the National School of Computer Science and Applied Mathematics of Grenoble.

Show more...

Investment focus

  • Industry: Software, SaaS, Food and Beverage
  • Stage:Seed, Pre-Seed, Angel
  • Geography: France, United States, United Kingdom

Investor stats

  • Total investments: 26
  • Round size: Seed $637k–$10M; Angel $400k–$500k; Pre-Seed $200k–$2M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • GOURMEY — We create sustainable cultivated meat delights for an uncompromising and conscious generation.
  • Waldo — The codeless way to quickly build a comprehensive test suite for teams who don't compromise on speed and quality.
  • TOTEM — A Totem is a place of sharing and conviviality in your office. This is an opportunity for your colleagues to get to know each other better, celebrate victories and defeats together, and build a solid culture.
Show all investments...

Roche Venture Fund
VC Fund · Basel, Basel-Stadt, Switzerland · 1 investments in France Life Science startups

We are the corporate venture fund of Roche, a global leader in bringing medicines and in vitro diagnostics to the benefit of patients.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series B, Series A, Series C
  • Geography: United States, United Kingdom, Spain

Investor stats

  • Total investments: 110
  • Lead/follow: no public data

Portfolio highlights

  • DiogenX — Welcome to DiogenX. Explore our pioneering research and innovative therapies aimed at transforming diabetes treatment
  • Mironid — Google Analytics is a web analysis service provided by Google. Google utilizes the data collected to track and examine the use of www.mironid.com, to prepare reports on its activities and share them with other Google services. Google may use the data collected to contextualize and personalize the ads of its own advertising network.
  • MISSION Therapeutics — Deubiquitylating enzymes: multiple drug opportunities across therapeutic areas
Show all investments...

Sofipaca
VC Fund · Aix-en-provence, Provence-Alpes-Cote d'Azur, France · 1 investments in France Life Science startups

Sofipaca supports SMEs and mid-caps in the SOUTH region in the long term in their development capital and transmission capital operations. The company was founded in 1984 and based in Aix en Provence, France.

Show more...

Investment focus

  • Industry: Food and Beverage, Pharmaceutical, Manufacturing
  • Stage:Private Equity, Series A, Series B
  • Geography: France

Investor stats

  • Total investments: 9
  • Lead/follow: no public data

Portfolio highlights

  • HalioDx — Veracyte translates the tumor immune response into clear insights to guide treatment decisions, inform biomarker development, or advance therapeutics.
  • Cintoo — Cintoo is essential for BIM to bridge the gap between your physical and virtual worlds.
  • Keep Cool — Keep Cool is a operator of a chain of fitness centers.
Show all investments...

Afone Participations
VC Fund · Paris, Ile-de-France, France · 1 investments in France Life Science startups

Afone Participations is a telecommunications and electronic payments company.

Show more...

Investment focus

  • Industry: Software, Compliance, Life Science
  • Stage:Series A
  • Geography: France

Investor stats

  • Total investments: 1
  • Lead/follow: no public data

Portfolio highlights

  • BMI System — BMI System is a management software editor for the pharmaceutical, medical, and cosmetics industries The company exports its software packages to Europe and America. With the NAYA Compliance application it has established itself as the leading French company for regulatory compliance software for the pharmaceutical industry.
Show all investments...

Calao Finance
VC Fund · Paris, Ile-de-France, France · 1 investments in France Life Science startups

CALAO Finance is an independent private equity company, specialized in financing European SME.

Show more...

Investment focus

  • Industry: Information Technology, Software, Big Data
  • Stage:Series A, Series B
  • Geography: France, United States

Investor stats

  • Total investments: 22
  • Lead/follow: no public data

Portfolio highlights

  • ISYBOT — ISYBOT is a designer and manufacturer of collaborative robots or "Cobots", that is to say, robots working in collaboration with workers. Its cobots work with workers and make it possible to: - reduce the arduousness of workstations - multiply their productivity - enhance manual workstations ISYBOT is based on a breakthrough technicalinnovation, resulting from 15 years of R&D carried out within CEA LIST .
  • Kalray — DPU processors, accelerator cards, software-defined storage and data management solutions for high-performance, data-centric computing.
  • ISYBOT — ISYBOT is a designer and manufacturer of collaborative robots or "Cobots", that is to say, robots working in collaboration with workers. Its cobots work with workers and make it possible to: - reduce the arduousness of workstations - multiply their productivity - enhance manual workstations ISYBOT is based on a breakthrough technicalinnovation, resulting from 15 years of R&D carried out within CEA LIST .
Show all investments...

Capitole Angels
VC Fund · Toulouse, Midi-Pyrenees, France · 1 investments in France Life Science startups

Capitole Angels is to create this association was born from the experience of many of its founders in the field of start-ups including the following observations. Need a structure enabling them to meet investors / promoters of the project. Plethora of potential investors hampered by the lack of an open structure. A region rich in technology,its universities, laboratories and therefore the bearer of innovation.

Show more...

Investment focus

  • Industry: Information Technology, Software, 3D Technology
  • Stage:Seed, Angel
  • Geography: France

Investor stats

  • Total investments: 21
  • Lead/follow: no public data

Portfolio highlights

  • Hoope — Hoope offers crunchy mueslis, spreads, and biscuits rich in nutrients, all organic, without palm oil, additives.
  • Deepbloo — DeepBloo is a Sales and Market Intelligence platform. We provide : + 5.8 millions tenders and market information Worldwide and + 300 000 tenders in France
  • Sensivic — Designed and manufactured in France, SENSIVIC smart audio detection systems add meaning to your security. Our solutions automatically detect and alert you in real time as soon as an abnormal sound or suspicious noise occurs.
Show all investments...

Societe Generale Asset Management
VC Fund · Paris, Ile-de-France, France · 1 investments in France Life Science startups

SGAM AI is a leading institutional player in Alternative Investment Management. SGAM AI successfully mixes the cultures of asset management and capital markets. They are client driven and institutional, like an asset manager. Their approach of each market is entrepreneurial and financial, like an investment bank. They offer the widest coverage ofAlternative Investment classes. Their size and profitability allow long term investments and credibility. They have the ability to offer solutions, not only products. SG Group's strengths are brought to the Alternative Investment's industry. They benefit from SG Group's long term commitment in Alternative Investments. They use the processes ans resources of SGAM Group (rated M2 by Fitch).

Show more...

Investment focus

  • Industry: Biotechnology, Software, Health Care
  • Stage:Series B, Series A
  • Geography: France, United States, Germany

Investor stats

  • Total investments: 47
  • Lead/follow: no public data

Portfolio highlights

  • Augure — Improve your brand performance with Launchmetrics' leading software solutions for fashion, lifestyle and beauty brands
  • Force-A — FORCE-A designs, produces, and sells optical sensors for the assessment of physiological and health status of crops. It offers crop sensors for nondestructive assessment of leaf polyphenolics. The company also provides multiparameter noncontact sensors-based on leaves or fruits, and berries autofluorescence measurements. Its multiparameternoncontact sensor provides inputs for decision support systems for a range of crops, including fertilisation needs, weed infestation, crop diseases, and crop yield and quality forecast. The company was founded in 2004 and is based in Orsay, France.
  • METRIXWARE — Metrixware has, since 1995, been providing software maintenance & quality management solutions to CIOs and IT professionals through its System Code range of application management tools. The company provides global organizations with information, indicators and diagnostic to streamline decision making and implement best practice and compliancestandards.
Show all investments...

Life Science Investor funding in France at a glance

Stats across 206 deals from 309 investors.

309
investors
in France Life Science startups
206
deals
in France Life Science startups
$5M
median round
in France Life Science startups
34%
lead investors
lead at least one round
22%
Seed
most common funding stage
96/4
VC / Angel
share of investor count

Access all 309 investors in France Life Science startups.

Open List

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Life Science Investors in France investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 309 investors investing in France Life Science startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists